{{ subpage.title }}

UK vaccine rollout a key chance to learn; Brexit trade deal is razor close

Ian Bremmer discusses the World In (more than) 60 Seconds:

COVID vaccine rollout has begun in the UK. What's next?

Well, I was so pleased to see that the second person to get the vaccine in the UK is William Shakespeare. Some 86-year-old guy living in the UK. Of course, of course he is. It's also nice for the UK, finally have some good news about something. It's been all Brexit and economic disaster and Boris Johnson, bad news on coronavirus. First, it's herd immunity, then it's not. It's lockdown, it's not. But the first advanced industrial democracy to start getting vaccines out there and capping off an extraordinary year in terms of vaccine development. Really Moore's law for vaccines. It's very, very, very exciting. What happens next is we learn a lot. One of the big mistakes that we made in the United States is we had a couple of weeks when the virus was exploding in Europe and we were twiddling our thumbs in the United States. We weren't prepping, we weren't watching what was happening in Italy and making sure that we understood the type of coordination we needed, the type of testing we needed, the type of contact tracing we needed. As a consequence, some critical time was wasted. We need to be watching very carefully what problems the UK has, challenges in rolling out this vaccine. First vaccine we see right now from Pfizer, that's the one that's most challenging from an infrastructure perspective. It's the one that needs the proprietary cold chain capability, super low temperatures, South Pole type temperatures. It needs labor on site that can dilute the vaccine right before it is administered. Those are things you can do easily in good hospitals. It's not an easy thing to roll out across a countryside.

Read Now Show less

Subscribe to GZERO Media's newsletter, Signal

Latest